As a pharmaceutical company with a strong focus on innovation, BrightGene covers several core areas. These include the development of APIs, the manufacturing of complex pharmaceutical preparations, as well as the production of both generic and innovative drugs to meet clinical needs worldwide.

We look forward to continue our long and trusting partnership to safely bring quality APIs and pharmaceutical innovations to the European market.

作为博瑞生物的欧盟业务的GMP咨询方，PharmaKorell一直以来都为我们提供专业且高效的服务。我们的质量管理水平和质量理念能够达到目前的水平，且顺利通过三次欧盟的GMP检查，离不开PharmaKorell长期以来的指导和卓有成效的培训。我们相信与PharmaKorell的合作在GMP管理方面将使我们长期受益。